| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Chief Clinical Officer
1 company
Winston Roy is a Chief Medical Officer at Pacira BioSciences, Inc.. Recent SEC Form 4 filings include 1 buy and 19 sells.
Estimated insider holdings value: $1.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 2, 2023 | PCRX Pacira Biosciences, Inc. | Chief Medical Officer | Sell | 509 | $34.88 | $17,751.38 | -1.0% | -23.0% | -43.5% | |
| Jun 7, 2023 | PCRX Pacira Biosciences, Inc. | Chief Medical Officer | Sell | 3,636 | $38.42 | $139,680.29 | -4.1% | -7.4% | -22.4% | |
| Aug 3, 2022 | PCRX Pacira Biosciences, Inc. | Chief Medical Officer | Sell | 476 | $55.70 | $26,513.20 | -1.0% | -9.4% | -33.1% | |
| Jun 6, 2022 | PCRX Pacira Biosciences, Inc. | Chief Medical Officer | Sale+OE | 17,546 | $61.39 | $1,077,135.48 | -4.5% | -15.5% | -35.6% | |
| Jun 4, 2021 | PCRX Pacira Biosciences, Inc. | Chief Clinical Officer | Sell | 2,276 | $61.04 | $138,920.21 | -8.7% | -2.8% | +5.5% | |
| Mar 31, 2021 | PCRX Pacira Biosciences, Inc. | Chief Clinical Officer | Sale+OE | 22,224 | $70.61 | $1,569,195.17 | -20.5% | -13.4% | +8.9% | |
| Nov 13, 2020 | PCRX Pacira Biosciences, Inc. | Chief Clinical Officer | Sell | 5,000 | $62.00 | $310,000.00 | -12.6% | - | - | |
| Mar 11, 2020 | PCRX Pacira Biosciences, Inc. | Chief Clinical Officer | Buy | 2,500 | $36.50 | $91,250.00 | +11.0% | - | - | |
| Jun 4, 2019 | PCRX Pacira Biosciences, Inc. | Chief Clinical Officer | Sell | 722 | $42.91 | $30,981.02 | -4.2% | - | - |